Myriad Genetics
MYGN
#7303
Rank
โ‚น53.84 B
Marketcap
โ‚น570.14
Share price
-0.17%
Change (1 day)
48.39%
Change (1 year)

Myriad Genetics (MYGN) Fails to deliver data

Key failure to deliver metrics for Myriad Genetics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Myriad Genetics (MYGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Myriad Genetics (MYGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Myriad Genetics (MYGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚น0.12 M-86.62%
2025โ‚น0.91 M59.23%
2024โ‚น0.57 M-66.71%
2023โ‚น1.72 M-31.63%
2022โ‚น2.51 M-65.06%
2021โ‚น7.2 M55%
2020โ‚น4.64 M-57.42%
2019โ‚น10.91 M-16.03%
2018โ‚น12.99 M-66.88%
2017โ‚น39.23 M37.96%
2016โ‚น28.44 M-83.11%
2015โ‚น0.16 B-65.22%
2014โ‚น0.48 B171.86%
2013โ‚น0.17 B

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Abbott Laboratories
ABT
โ‚น0.16 Bโ‚น0.27 B๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
N/Aโ‚น90.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น4.78 Mโ‚น14.96 M๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
โ‚น3.88 Mโ‚น3.88 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚น25.9 Mโ‚น61.96 M๐Ÿ‡บ๐Ÿ‡ธ USA